Bayesian Number-Needed-to-Treat Analysis of Rosuvastatin for Prevention of Venous Thromboembolism in Patients with Elevated High Sensitivity C-Reactive Protein

被引：0
|
作者：
Lang, Christopher
Arora, Rohit
机构：
[1] Univ Rochester, Rochester, NY USA
[2] Chicago Med Sch, Rochester, NY USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Pulmonary embolism; Statins; Pharmacology;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A20862
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Rosuvastatin in Patients with Elevated C-Reactive Protein
    Koller, Michael T.
    Bucher, Heiner C.
    Steyerberg, Ewout W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10): : 1041 - 1041
  • [2] Rosuvastatin reduced venous thromboembolism in healthy older adults with elevated C-reactive protein levels
    Levi, Marcel
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (06)
  • [3] High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study
    Hald, Erin M.
    Braekkan, Sigrid K.
    Mathiesen, Ellisiv B.
    Njolstad, Inger
    Wilsgaard, Tom
    Brox, Jan
    Hansen, John-Bjarne
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1189 - 1194
  • [4] Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)
    Ridker, Paul M.
    MacFadyen, Jean G.
    Fonseca, Francisco A. H.
    Genest, Jacques
    Gotto, Antonio M.
    Kastelein, John J. P.
    Koenig, Wolfgang
    Libby, Peter
    Lorenzatti, Alberto J.
    Nordestgaard, Borge G.
    Shepherd, James
    Willerson, James T.
    Glynn, Robert J.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (06): : 616 - 623
  • [5] Elasticity and vasodilation in patients with elevated high sensitivity C-reactive protein levels
    Saban-Ruiz, Jose
    Sanchez, Olivia
    Fabregate, Rosa
    Fabregate, Martin
    Redondon, Sandra
    De la Torre, Nuria
    Ugalde-Canitrot, Arturo
    DIABETES, 2007, 56 : A599 - A599
  • [6] Use of Rosuvastatin in Preventing Vascular Events in Patients with Elevated C-Reactive Protein
    Guthrie, Robert M.
    POSTGRADUATE MEDICINE, 2010, 122 (02) : 169 - 171
  • [7] Elevated serum levels of high sensitivity C-reactive protein in chronic hepatitis C patients
    Huang, C. F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A174 - A174
  • [8] Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism
    Vormittag, R
    Vukovich, T
    Schönauer, V
    Lehr, S
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Pabinger, I
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (03) : 488 - 493
  • [9] The backstage of the patient with elevated high sensitivity C-reactive protein levels
    Saban-Ruiz, J
    Marquez, J
    Sanchez-Largo, E
    Coca, D
    Sanchez, O
    Bernal, E
    Ugalde, A
    Calbacho, M
    Fabregate, R
    Fabregate, M
    JOURNAL OF HYPERTENSION, 2005, 23 : S58 - S58
  • [10] INTERACTION BETWEEN ROSUVASTATIN AND HIGH SENSITIVITY C-REACTIVE PROTEIN ON PROGRESSION OF AORTIC STENOSIS
    Chan, Kwan-Leung
    Ni, Andy
    Tam, James
    Sochowski, Randall
    Dumesnil, Jean G.
    Giannoccaro, John P.
    Jue, John
    Pandey, A. Shekhar
    Joyner, Cam
    Teo, Koon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
12345